carter.gif (66179 bytes)

Dean E. Carter,

Professor of Pharmacology and Toxicology, Ph.D., University of Arizona, 1969

dean.carter@pharmacy.arizona.edu

 

Toxicity of Arsenic compounds; analytical toxicology; toxicokinetics

Research Activities

Metabolism and Toxicity of Arsenic Compounds in the Lung and Blood
Toxic arsenic compounds are widespread in our environment due to both natural and industrial processes but their toxicity is not well understood.  We do not understand why humans are about 100 times more sensitive to the toxic effects of arsenic as compared to animals or how arsenic causes cancer.  Part of the answers may relate to arsenic metabolism but, despite knowing the products of metabolism, the routes and responsible enzymes have not been identified.  Arsenic metabolism is a combination of oxidation-reduction and methylation reactions.  Inorganic arsenic which is released to the environment is in two oxidation states: arsenite (As(III)) and arsenate (As(V)).  When exposure occurs to either form, the arsenic is converted partially to the other oxidation state and is also metabolized partially to methylated compounds (monomethylarsonic acid and dimethylarsinic acid).  Our hypothesis is that arsenic toxicity in a given species or at a given dose depends on the rate of metabolism in the target tissue.  Related to this is the hypothesis that the rate of metabolism also depends on the extent of uptake of the various arsenic species into the target tissue.  We have chosen to study two target tissues: the lung and the blood.  Our studies examine the metabolism and uptake of arsenic in the lung and in the red blood cell.  Recent experiments have shown chemical evidence that the reduction reactions are mediated by glutathione and currently we are testing the idea that GSH is responsible for these reactions in vivo.  It is also possible that GSH influences uptake through the formation of complexes with arsenic; our laboratory has isolated some of these complexes.  This work will be followed by an investigation of species differences in this metabolism.

Mechanism of Arsine-induced Hemolysis and Its Possible Treatment
Arsine, the hydride of arsenic (AsH3), is used extensively in the electronics industry as a dopant and in the synthesis of gallium arsenide devices.  It is very toxic and attacks the erythrocyte to cause massive hemolysis.  If death does not occur immediately, it often occurs from renal failure when the fragments of the red cell accumulate in the kidney.  Arsine is a gas at room temperature and this causes problems in designing quantitative experiments.  Arsine is slightly soluble in water but reaches concentrations which can rapidly cause hemolysis.  We have developed procedures to prepare reproducible solution concentrations and to allow arsine to be incubated with red blood cells.  Arsine was found to be taken up by the red cell in less than one minute and glutathione was somewhat depleted.  However, the amount of depletion was relatively small and hemolysis started before GSH depletion was significant.  Our current hypothesis is that the arsine is interacting with the iron in hemoglobin and this interaction forms the reactive species which cause hemolysis.

 

Close This Window